Friday , October 20 2017
Home / Therapies / SGLT-2 Therapy Center / Christophe Arbet-Engels, MD, Q3: Cooperation between Boehringer and Lilly

Christophe Arbet-Engels, MD, Q3: Cooperation between Boehringer and Lilly

Dr. Christophe Arbet-Engels explains how Eli Lilly and Boehringer Ingelheim have created and alliance and what that means in terms of promotion. 

Christophe Arbet-Engels, MD, PhD, MBA, is vice president, metabolic-clinical development and medical affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

See more SGLT-2 Resources